Aditxt, Inc. Current Liabilities
Aditxt, Inc. (ADTX) had Current Liabilities of $13.34 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-05-20
- 2026-03-31: Liabilities, Current $13.34M.
- 2025-12-31: Liabilities, Current $12.22M.
- 2025-09-30: Liabilities, Current $20.66M.
- 2025-06-30: Liabilities, Current $20.58M.
| Period end | Liabilities, Current |
|---|---|
| 2026-03-31 | $13.34M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $12.22M 10-Q · filed 2026-05-20 |
| 2025-09-30 | $20.66M 10-Q · filed 2025-11-18 |
| 2025-06-30 | $20.58M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $15.18M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $23.41M 10-K · filed 2026-03-31 |
| 2024-09-30 | $24.37M 10-Q · filed 2024-11-18 |
| 2024-06-30 | $20.57M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $17.30M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $25.89M 10-K · filed 2025-03-31 |
| 2023-09-30 | $11.24M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $9.74M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.91M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.64M 10-K · filed 2024-04-16 |
| 2022-09-30 | $4.37M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.04M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.51M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.61M 10-K · filed 2023-04-17 |
| 2021-09-30 | $3.60M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.23M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.40M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.23M 10-K · filed 2022-03-31 |
| 2020-09-30 | $755.79K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $4.33M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $2.98M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |